How to Buy Edwards Lifesciences Stock

Edwards Lifesciences Corp

Edwards Lifesciences is a medical device company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker EW on the NYSE exchange.

Edwards Lifesciences stock last closed at $83.08, down 1.38% from the previous day, and has increased 12.32% in one year. It has overperformed other stocks in the Medical Devices industry by 0.45 percentage points. Edwards Lifesciences stock is currently +25.99% from its 52-week low of $65.94, and -5.47% from its 52-week high of $87.89.

At the moment, there are 580M shares of EW outstanding. The market value of EW is $48.19B. In the last 24 hours, 2.05M EW shares were traded.

How to Buy Edwards Lifesciences Stock

Wondering how to invest in Edwards Lifesciences stock? Here's how.

  1. Choose where to buy Edwards Lifesciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Edwards Lifesciences stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Choose your method of payment and add your details.
  4. Analyze Edwards Lifesciences stock: The Edwards Lifesciences ticker symbol is EW. Is Edwards Lifesciences stock a good investment? Should you buy shares of EW? How do EW's underlying business fundamentals look? Do top analysts think Edwards Lifesciences is a good buy? Why has EW's stock price moved recently? (Hint: Our stock research tools can help you evaluate if EW is a good stock to buy).
  5. Place your EW trade: Decide if you will purchase EW shares at the current market price or use a limit order to purchase EW shares at a particular price.
  6. Keep an eye on your EW investment: Create a watchlist to watch your new investment in Edwards Lifesciences shares.

Step 1: Choose where to buy Edwards Lifesciences stock

You will need an online brokerage account in order to access the NYSE market and buy EW shares.

A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to buy EW stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create your new brokerage account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you've created your account on one of the most highly reviewed stock market apps, you need to deposit funds:

Check out the walkthrough below if you need help transferring funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Edwards Lifesciences stock

Once you have chosen the best place to buy Edwards Lifesciences stock, it's absolutely critical to analyze their stock prior to buying, so you actually comprehend the risk and opportunity.

Edwards Lifesciences stock data

EW Price
$83.08
1w %
-3.61%
1y %
12.32%
5y %
-0.59%
P/E
35.35x
P/B
4.72x
P/S
8.26x
PEG
3.04x
Revenue
$5.88B
Earnings
$1.37B
Fore. Rev. Growth
8.36%
Fore. Earn. Growth
11.62%
Market Cap
$48.19B
Next Earnings
Feb 4, 2026
Next Dividend
N/A

Edwards Lifesciences Due Diligence Checks

WallStreetZen was built to help average investors do more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on EW's stock page.

How is EW stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge EW's fair value.

Using relative valuations ratios:

  • EW could be overvalued based on its P/E ratio of 35.35x, relative to Medical Devices industry P/E ratio of 24.46x
  • EW may be overvalued based on its P/B ratio of 4.72x, relative to Medical Devices industry P/B ratio of 3.88x
  • EW may be overvalued based on its PEG ratio of 3.04x

You can do additional valuation research on EW's stock here.

A look at EW Cashflows and Balance Sheet

Passed Financial Due Diligence Checks:

  • There are more short-term assets than long-term liabilities on the EW balance sheet.
  • EW earnings of $1.62B is not sufficient to cover its interest payments.
  • EW's operating cash flow of $1.02B allows it to safely service it's debt of $700.30M.
  • There are more short-term assets than short-term liabilities on the EW balance sheet.
  • Total EW debt is lower than 5 years ago, relative to shareholder equity.
  • EW has a low debt to equity ratio of 0.3.

Failed Financial Due Diligence Checks:

  • EW profit margin has gone down from 78.2% to 23.2% in the past year.

Is it a good time to buy EW stock, according to analysts?

Out of 18 Equities analysts who research EW, the consensus analyst rating on EW is a Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

Latest EW Analyst Upgrades/Downgrades

Larry Biegelsen, a top 14% analyst from Wells Fargo maintains EW with a strong buy rating and raises their EW price target from $95.00 to $96.00, on Dec 5, 2025.

Richard Newitter, a top 9% analyst from Truist Securities maintains EW with a hold rating and raises their EW price target from $90.00 to $92.00, on Dec 5, 2025.

Shagun Singh, a top 22% analyst from RBC Capital maintains EW with a buy rating and raises their EW price target from $95.00 to $100.00, on Dec 5, 2025.

David Rescott, a top 16% analyst from Baird maintains EW with a hold rating and raises their EW price target from $83.00 to $88.00, on Dec 5, 2025.

Marie Thibault, a top 17% analyst from BTIG maintains EW with a strong buy rating and raises their EW price target from $100.00 to $103.00, on Dec 5, 2025.

BTIG's Marie Thibault raised their price target on Edwards Lifesciences (NYSE: EW) by 3% from $100 to $103 on 2025/12/05. The analyst maintained their Strong Buy rating on the stock.

Edwards Lifesciences held its 2025 Investor Conference on 2025/12/04.

Potential catalysts in 2026 that could drive the next few years' momentum, according to Thibault, include:

  • A possible NCD.
  • Modifications to guidelines.
  • New product introductions.

You can dig deeper into what analysts are forecasting on the Edwards Lifesciences stock forecast page.

EW Momentum

SMA10
84.48
SMA20
85
SMA50
81.42
SMA100
79.93
SMA200
77.01
MACD
0.44
MACD Signal
0.95
MACD Histogram
-0.51
RSI
46.64
Stochastic %K
14.13
Stochastic %D
14.63
StochRSI %K
12.09
StochRSI %D
9.67

Is EW Growing Revenue?

Last year, EW earnings were $1.37B. During the last 5 year, EW's earnings have grown by 13.1% per year. This was slower than the Medical Devices industry average of 14.21%.

Last year, EW revenue was $5.88B. Over the past five year, EW's revenue has gone up by 6.14% per year. This was slower than the Medical Devices industry average of 10.92%.

Dig into EW's earnings and revenue performance here.

Who is buying/selling EW?

In the past year, executives and large shareholders at EW have sold more shares than they have bought.

Donald E. Bobo Jr., CVPStrategyCorp Development of EW, was the latest EW insider to sell. They sold $459,671.94 worth of EW shares on Dec 12, 2025.

Learn more about who owns EW stock here.

Can I rely on EW as an income stream?

No, Edwards Lifesciences doesn't provide an income stream by paying out dividends.

What do other investors have to say about EW?

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Place your EW trade

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.

Press the Open button and your broker will execute your order.

If you require additional help investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep an eye on your EW investment

Now that you own some EW stock, you'll want to stay up-to-date on your stock purchase.

Put EW on a watchlist to get the latest updates about your EW stock.

EW Feed

How to Buy Stock in Edwards Lifesciences

To summarize, here are the 6 steps for buying Edwards Lifesciences stock:

  1. Choose where to buy Edwards Lifesciences stock
  2. Create your brokerage account
  3. Fund your investment account
  4. Analyze Edwards Lifesciences stock
  5. Place your EW trade
  6. Keep an eye on your EW investment

If you require a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep an eye on your investment in Edwards Lifesciences, get started below.

NYSE: EW
$83.08-1.16 (-1.38%)
Updated Dec 12, 2025
Open eToro Account
Your capital is at risk.
NYSE: EW
$83.08-1.16 (-1.38%)
Updated Dec 12, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Edwards Lifesciences share?

As of Dec 12, 2025, it costs $83.08 to buy one share of Edwards Lifesciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.12 shares of EW.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Edwards Lifesciences stock?

According to 18 Wall Street analysts who monitor Edwards Lifesciences, their consensus recommendation is to buy Edwards Lifesciences stock.

What is the best way to buy Edwards Lifesciences stock?

One way to place an order for Edwards Lifesciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.